Account
DDB Mudra wins the creative mandate for Narayana One Health
Mumbai: Narayana One Health, part of the leading Indian healthcare provider Narayana Health Group, has awarded its creative and experiential marketing mandate to DDB Mudra following a multi-agency pitch. The mandate focuses on creating a unique brand identity that reflects the consumers’ evolving demands from the healthcare industry and making service offerings more accessible and easier to understand.
Starting with Bangalore, Narayana One Health plans to build a truly integrated healthcare offering that combines comprehensive healthcare, personalized care plans, and seamless health insurance. Customers will be able to access care through a wide network of clinics across the country and on state-of-the-art digital tools. Narayana One Health will leverage the latest data science, AI, and ML tools to create bespoke experiences to help its customers get and stay healthy.
The account will be handled by the agency’s Bengaluru office.
Narayana One Health CEO Ravi Vishwanath said, “We are on a mission to make healthcare simple, integrated, personalized and friendly. This strategy is new to India and communicating the benefits of our approach is a critical task. We are delighted to partner with DDB Mudra and look forward to their strategic collaboration on this pathbreaking journey.”
Commenting on the win, DDB Mudra president and managing partner – growth and strategy, Menaka Menon said, “With their focus on bringing primary and secondary healthcare closer to the consumer and addressing the many barriers that come in the way of a proactive approach to health, Narayana One Health is here to make a difference to the way healthcare is organized in India. We’re really excited about partnering with the team and bringing about a change in the way Indians interact with healthcare.”
Account
BigTrunk Communications wins digital mandate for Soframycin
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”








